Results for tag: "Respiratory Depression Drug"

The Respiratory Depression Drug market is a subset of the larger Respiratory Drugs market. It includes drugs used to treat respiratory depression, a condition in which breathing is slowed or stopped due to a decrease in the amount of oxygen in the blood. These drugs are used to treat a variety of conditions, including asthma, COPD, and sleep apnea. They can also be used to treat opioid-induced respiratory depression. Common drugs in this market include opioids, benzodiazepines, and barbiturates. Some companies in the Respiratory Depression Drug market include Pfizer, GlaxoSmithKline, Merck, and Novartis. Other companies include Sanofi, AstraZeneca, and Teva Pharmaceuticals. Show Less Read more